Clinical Trial Update: Aspirin for Prophylaxis of TTP [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating aspirin for prophylaxis of thrombotic thrombocytopenic purpura is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Thrombotic Thrombocytopenic Purpura | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING